Clinical Trial Update: Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effectiveness of a single dose of the nonavalent HPV vaccine (Gardasil 9) in young-adult women in Sweden who are pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Karolinska Institutet | Conditions: Incident HPV16, 18, 31, 33, 45, 52 or 58 Infection | Phase 4 | Status: ACTIVE_NOT_RECRUITING